MEMBER LOGIN


Follow MVCC on:
 Follow MVCC on Facebook

Our Participating Clinics and Hospitals

Clinical Trials

Trials New This Month

View Clinical Trials
A Randomized Phase III trial of Dabrafenib + Trametinib followed by Ipilimumab + Nivolumab at Progression vs. Ipilimumab + Nivolumab followed by Dabrafenib + Trametinib at Progression in Patients With Advanced BRAFV600 Mutant Melanoma
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Regorafenib Dose Optimization Study (ReDOS): A Phase II Randomized Study of Lower Dose Regorafenib Compared to Standard Dose Regorafenib in Patients with Refractory Metastatic Colorectal Cancer (mCRC)
Molecular Analysis for Therapy Choice (MATCH)
View Clinical Trials
Missouri Valley Cancer Consortium
6818 Grover Street * Executive Plaza, Suite 301* Omaha, NE 68106
(402) 991-8070